Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5131 to 5145 of 8314 results

  1. Interventions for tricuspid regurgitation: What is the most clinically and cost-effective management strategy for adults with tricuspid regurgitation?

    Recommendation ID NG208/02 Question Interventions for tricuspid regurgitation: What is the most clinically and cost-effective management

    Research recommendation
    Published
    16 December 2021

  2. Antibiotics for suspected early-onset infection: What is the incidence in England and Wales of resistance to commonly used antibiotics among bacteria that cause early-onset neonatal infection?

    Recommendation ID NG195/11 Question Antibiotics for suspected early-onset infection: What is the incidence in England and Wales of resistance

    Research recommendation
    Published
    6 August 2021

  3. Managing acute hydrocephalus: What is the most clinically and cost-effective method of cerebrospinal fluid drainage or diversion (for example shunt surgery, external ventricular drain surgery or lumbar drain) for symptomatic acute hydrocephalus?

    Recommendation ID NG228/07 Question Managing acute hydrocephalus: What is the most clinically and cost-effective method of cerebrospinal

    Research recommendation
    Published
    12 December 2022

  4. What is the incidence of lentigo maligna diagnosed in England and which different therapies are used to treat lentigo maligna?

    Recommendation ID DG19/5 Question What is the incidence of lentigo maligna diagnosed in England and which different therapies are used

    Research recommendation
    Published
    12 January 2016

  5. Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective monitoring strategy (type and frequency of test) for adults with asymptomatic severe heart valve disease (aortic regurgitation, mitral stenosis, mitral regurgitation or tricuspid regurgitation) and no current indication for intervention?

    Recommendation ID NG208/19 Question Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective

    Research recommendation
    Published
    16 December 2021

  6. Long-term complications of spondyloarthritis:- What is the incidence of long-term complications, in particular osteoporosis, cardiovascular disease (CVD) and metabolic syndrome, in people with spondyloarthritis, and how does this compare with the general population? Are any specific spondyloarthritis features or risk factors associated with the incidence and outcomes of these complications?

    Recommendation ID NG65/2 Question Long-term complications of spondyloarthritis:- What is the incidence of long-term complications, in particular

    Research recommendation
    Published
    4 May 2017

  7. Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective monitoring strategy (type and frequency of test) for adults with symptomatic moderate heart valve disease (aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation and tricuspid regurgitation) and no current indication for intervention?

    Recommendation ID NG208/20 Question Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective

    Research recommendation
    Published
    16 December 2021

  8. Long-term effectiveness of total hip replacement: What is the long-term clinical and cost effectiveness for adults (including different subgroups) undergoing total hip replacement compared with hemiarthroplasty for displaced intracapsular hip fracture?

    Recommendation ID CG124/06 Question Long-term effectiveness of total hip replacement: What is the long-term clinical and cost effectiveness

    Research recommendation
    Published
    3 February 2023

  9. Monitoring when there is no current need for intervention: What is the most clinically and cost-effective monitoring (type and frequency of test) for adults with asymptomatic mild or moderate heart valve disease (aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation and tricuspid regurgitation) and no current need for intervention?

    Recommendation ID NG208/01 Question Monitoring when there is no current need for intervention: What is the most clinically and cost-effective

    Research recommendation
    Published
    16 December 2021

  10. Prophylactic antibiotics for preventing exacerbations: - What is the long-term clinical and cost effectiveness of prophylactic antibiotics for people with stable COPD who are at high risk of exacerbations?

    Recommendation ID NG115/7 Question Prophylactic antibiotics for preventing exacerbations: - What is the long-term clinical and cost effectiveness

    Research recommendation
    Published
    13 February 2019

  11. What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate cancer?

    Recommendation ID NG131/4 Question What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate

    Research recommendation
    Published
    7 January 2022

  12. Long-term effectiveness of selective laser trabeculoplasty: What is the long-term effectiveness and cost effectiveness of selective laser trabeculoplasty as a first-line treatment compared with intraocular pressure-lowering eye drops in ocular hypertension or COAG in adults?

    Recommendation ID NG81/2 Question Long-term effectiveness of selective laser trabeculoplasty: What is the long-term effectiveness and cost

    Research recommendation
    Published
    1 February 2022

  13. Non-steroidal anti-inflammatory drugs (NSAIDs) – route of administration:- What is the most clinically and cost effective route of administration for NSAIDs in the management of acute pain thought to be due to renal or ureteric stones?

    Recommendation ID NG118/5 Question Non-steroidal anti-inflammatory drugs (NSAIDs) – route of administration:- What is the most clinically

    Research recommendation
    Published
    7 March 2019

  14. Individual-level interventions: What is the long-term effectiveness and cost effectiveness of universal individual-level interventions on mental wellbeing in different types of organisations?

    Recommendation ID NG212/01 Question Individual-level interventions: What is the long-term effectiveness and cost effectiveness of universal

    Research recommendation
    Published
    8 April 2022

  15. Laboratory tests to diagnose initial and ongoing infection and determine re-infection in the different presentations of Lyme disease in the UK:- What is the most clinically and cost-effective serological antibody-based test, biomarker or other test for diagnosing Lyme disease in the UK at all stages, including re-infection?

    Recommendation ID NG95/5 Question Laboratory tests to diagnose initial and ongoing infection and determine re-infection in the different

    Research recommendation
    Published
    27 November 2018